PMDA — authorised 18 June 2019
- Marketing authorisation holder: ALEXION PHARMA GK
- Status: approved
PMDA authorised Ultomiris on 18 June 2019
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. PMDA authorised it on 18 June 2019.
ALEXION PHARMA GK holds the Japanese marketing authorisation.